Latest News and Press Releases
Want to stay updated on the latest news?
-
Enhancing emergency triage imaging with Nanox.ARC to improve efficiency and lower radiation dose Collaboration expands clinical evidence base of Nanox.ARC to support broader adoption PETACH TIKVA,...
-
SAN DIEGO and SUZHOU, China, April 14, 2026 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biotechnology company transforming the discovery and...
-
Dublin, April 14, 2026 (GLOBE NEWSWIRE) -- The "Clinical Trial Monitoring (June 18th - June 19th, 2026)" training has been added to ResearchAndMarkets.com's offering.With regulatory inspectors...
-
กรุงเทพฯ, April 13, 2026 (GLOBE NEWSWIRE) -- มีช่วงเวลาหนึ่งในทุกเดือนเมษายน ที่กรุงเทพฯ มีชีวิตชีวาในแบบที่ไม่มีที่ใดบนโลกสามารถเทียบได้ ถนนเต็มไปด้วยสีสันและการสาดน้ำ...
-
BANGKOK, April 13, 2026 (GLOBE NEWSWIRE) -- There is a moment each April when Bangkok comes alive in a way that nowhere else on earth can match. Streets flood with colour and water. Music thunders...
-
Wedbush LAFFER|TENGLER New Era Value ETF (Ticker: TGLR) reorganizes into Wedbush Series Trust, becoming part of Wedbush Fund Advisers’ ETF platform.
-
Fourth distribution agreement of 2026 strengthens Nanox’s U.S. commercial momentum PETACH TIKVA, Israel, April 13, 2026 (GLOBE NEWSWIRE) -- Nano X Imaging Ltd. (NASDAQ NNOX), a leader in innovative...
-
DALIAN, China, April 13, 2026 (GLOBE NEWSWIRE) -- CBAK Energy Technology, Inc. (NASDAQ: CBAT) ("CBAK Energy" or the "Company"), a leading manufacturer of lithium-ion and sodium-ion batteries and...
-
Dublin, April 13, 2026 (GLOBE NEWSWIRE) -- The "COVID 19 - Competitive Landscape, 2026" has been added to ResearchAndMarkets.com's offering. The report provides a detailed examination of over...
-
Approval in CSU for children 2 to 11 years of age is based on data from the LIBERTY-CUPID clinical trial program, including an extrapolation of efficacy data showing that Dupixent significantly...